[1]李 婧,李小凤,闫 妮,等.胰岛素抵抗代谢评分在中老年人群非酒精性脂肪性肝病筛查中的价值研究[J].陕西医学杂志,2023,52(6):688-692.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.011]
　LI Jing,LI Xiaofeng,YAN Ni,et al.Value of metabolic score for insulin resistance in screening non-alcoholic fatty liver disease in middle-aged and elderly people[J].,2023,52(6):688-692.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.011]
点击复制

胰岛素抵抗代谢评分在中老年人群非酒精性脂肪性肝病筛查中的价值研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年6期
页码:
688-692
栏目:
临床研究
出版日期:
2023-06-05

文章信息/Info

Title:
Value of metabolic score for insulin resistance in screening non-alcoholic fatty liver disease in middle-aged and elderly people
作者:
李 婧; 李小凤; 闫 妮; 刘玲娇
(陕西省人民医院内分泌科,陕西 西安 710068)
Author(s):
LI Jing; LI Xiaofeng; YAN Ni; LIU Lingjiao
(Department of Endocrinology,Shaanxi Provincial People's Hospital,Xi'an 710068,China)
关键词:
非酒精性脂肪性肝病;  胰岛素抵抗代谢评分;  稳态模型评估的胰岛素抵抗指数;  中老年人;  筛查
Keywords:
Non-alcoholic fatty liver disease;  Metabolic score for insulin resistance;  Homeostasis model assessment of insulin resistance;  Middle-aged and elderly people;  Screening
分类号:
R 575
DOI:
DOI:10.3969/j.issn.1000-7377.2023.06.011
文献标志码:
A
摘要:
目的:探讨胰岛素抵抗代谢评分(METS-IR)在中老年人群非酒精性脂肪性肝病(NAFLD)筛查中的价值。方法:收集40岁及以上人群1281例为研究对象,根据是否患有NAFLD分为非NAFLD组(946例)和NAFLD组(335例)。采集受试者的既往病史,进行体格检查、实验室检查及腹部超声检查。采用Logistic回归模型评价METS-IR与中老年人群NAFLD患病风险的相关性。采用受试者工作特征(ROC)曲线分析METS-IR对中老年人群NAFLD的筛查价值。结果:NAFLD组收缩压、舒张压、腰围、转氨酶、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、空腹血糖(FBG)、空腹胰岛素(FINS)、糖化血红蛋白(HbA1c)、体重指数(BMI)、METS-IR、稳态模型评估的胰岛素抵抗指数(HOMA-IR)高于非NAFLD组,高密度脂蛋白胆固醇(HDL-C)低于非NAFLD组(均P<0.05)。单因素Logistic回归分析结果发现,随着BMI、腰围、血压、转氨酶、TG、TC、LDL-C、HbA1c、FBG、FINS、HOMA-IR、METS-IR水平的升高,NAFLD患病风险增加; HDL-C越高,年龄越大,NAFLD患病风险越小(均P<0.05)。根据METS-IR四分位数将中老年人群分位四组,进行多因素Logistic回归分析,结果显示在校正了混杂因素后,以Q1组作为参照,Q2、Q3和Q4组NAFLD患病风险增加(均P<0.05)。ROC曲线分析显示,METS-IR对NAFLD的筛查价值高于HOMA-IR(P<0.05)。结论:在中老年人群中,METS-IR升高与NAFLD患病风险增加独立相关。METS-IR对NAFLD的筛查优于HOMA-IR,比HOMA-IR更有助于中老年人群NAFLD的早期筛查。
Abstract:
Objective:To investigate the value of metabolic score for insulin resistance(METS-IR)in screening non-alcoholic fatty liver disease(NAFLD)in middle-aged and elderly people.Methods:A total of 1281 people aged 40 years and over were enrolled in the study.According to whether they had NAFLD,they were divided into non-NAFLD group(946 cases)and NAFLD group(335 cases).The past medical history of the subjects was collected,and physical examination,laboratory tests and abdominal ultrasound were performed.Logistic regression model was used to evaluate the correlation between METS-IR and the risk of NAFLD in middle-aged and elderly people.ROC curve was used to analyze the screening value of METS-IR for NAFLD in middle-aged and elderly people.Results:The NAFLD group had higher systolic blood pressure,diastolic blood pressure,waist circumference,transaminase,triglyceride(TG),total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),fasting blood glucose(FBG),fasting insulin(FINS),glycosylated hemoglobin(HbA1c),body mass index(BMI),METS-IR,and homeostasis model assessment of insulin resistance(HOMA-IR)than the non-NAFLD group,and the high density lipoprotein cholesterol(HDL-C)in NAFLD group was lower than that in non-NAFLD group(all P<0.05).Univariate Logistic regression analysis showed that the risk of NAFLD increased with the increase of BMI,waist circumference,blood pressure,transaminase,TG,TC,LDL-C,HbA1c,FBG,FINS,HOMA-IR and METS-IR; the higher the HDL-C level,the older the age,the lower the risk of NAFLD(all P<0.05).The middle-aged and elderly people were divided into four groups according to the quartile of METS-IR,and multivariate Logistic regression analysis showed that after adjusting for confounding factors,with Q1 group as a reference,the risk of NAFLD in Q2,Q3,and Q4 groups increased(all P<0.05).ROC curve analysis showed that METS-IR had a higher screening value for NAFLD than HOMA-IR(P<0.05).Conclusion:Elevated METS-IR is independently associated with increased risk of NAFLD in middle-aged and elderly people.METS-IR is better than HOMA-IR in the screening of NAFLD,and is more helpful for the early screening of NAFLD in middle-aged and elderly people than HOMA-IR.

参考文献/References:

[1] Zhou H,Urso C,Jadeja V.Saturated fatty acids in obesity-associated inflammation[J].Journal of Inflammation Research,2020,13:1-14.
[2] Younossi Z.Non-alcoholic fatty liver disease—A global public health perspective[J].Journal of Hepatology,2019,70(3):531-544.
[3] Younossi Z,Tacke F,Arrese M,et al.Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J].Hepatology,2019,69(6):2672-2682.
[4] Li J,Zou B,Yeo Y,et al.Prevalence,incidence,and outcome of non-alcoholic fatty liver disease in Asia,1999-2019:A systematic review and meta-analysis[J].Lancet Gastroenterol Hepatol,2019,4(5):389-398.
[5] Zou Y,Zhong L,Hu C,et al.LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids:A 5-year longitudinal cohort study[J].Lipids in Health and Disease,2021,20(1):28.
[6] Rosso C,Kazankov K,Younes R,et al.Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease[J].Journal of Hepatology,2019,71(5):1012-1021.
[7] Fonseca J,Nunes G,Fonseca C,et al.Comment to:“EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease”[J].Journal of Hepatology,2017,66(2):465-466.
[8] Muniyappa R,Lee S,Chen H,et al.Current approaches for assessing insulin sensitivity and resistance in vivo:Advantages,limitations,and appropriate usage[J].Am J Physiol Endocrinol Metab,2008,294(1):e15-e26.
[9] Isokuortti E,Zhou Y,Peltonen M,et al.Use of HOMA-IR to diagnose non-alcoholic fatty liver disease:A population-based and inter-laboratory study[J].Diabetologia,2017,60(10):1873-1882.
[10] Liu X,Fan J,Pan S.METS-IR,a novel simple insulin resistance indexes,is associated with hypertension in normal-weight Chinese adults[J].Journal of Clinical Hypertension(Greenwich),2019,21(8):1075-1081.
[11] Yoon J,Jung D,Lee Y,et al.The metabolic score for insulin resistance(METS-IR)as a predictor of incident ischemic heart disease:A longitudinal study among Korean without diabetes[J].Journal of Personalized Medicine,2021,11(8):742.
[12] Bello-Chavolla O,Almeda-Valdes P,Gomez-Velasco D,et al.METS-IR,a novel score to evaluate insulin sensitivity,is predictive of visceral adiposity and incident type 2 diabetes[J].European Journal of Endocrinology,2018,178(5):533-544.
[13] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):163-166.
[14] 安 欣,刘鲁豫,王成凯.2型糖尿病患者尿微量白蛋白肌酐比值与非酒精性脂肪性肝病相关性分析[J].陕西医学杂志,2021,50(11):1416-1419.
[15] 唐颖慧,叶苗青,何瑾瑜,等.化脂复肝颗粒通过抑制TLR4/NF-κB/NLRP3减轻Kupffer细胞炎症改善非酒精性脂肪性肝病机制研究[J].陕西中医,2022,43(10):1359-1363,1368.
[16] Lee J,Park K,Lee H,et al.The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults[J].Clinical and Molecular Hepatology,2023,29(1):169-170.
[17] Cai X,Gao J,Hu J,et al.Dose-response associations of metabolic score for insulin resistance index with nonalcoholic fatty liver disease among a nonobese Chinese population:Retrospective evidence from a population-based cohort study[J].Disease Markers,2022,14:7729-7740.
[18] 刘玲娇,余湘尤,虢小丽.西安市职业人群非酒精性脂肪性肝病患病率及其危险因素调查研究[J].陕西医学杂志,2021,50(1):107-110.
[19] Ji L,Cai X,Bai Y,et al.Application of a novel prediction model for predicting 2-year risk of non-alcoholic fatty liver disease in the non-obese population with normal blood lipid levels:A large prospective cohort study from China[J].International Journal of General Medicine,2021,14:2909-2922.
[20] Hirschler V,Maccallini G,Sanchez M,et al.Association between triglyceride to HDL-C ratio and insulin resistance in indigenous Argentinean children[J].Pediatric Diabetes,2015,16(8):606-612.
[21] Chen Z,Qin H,Qiu S,et al.Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels:A retrospective cohort research[J].Lipids in Health and Disease,2019,18(1):162.
[22] Mota M,Banini B,Cazanave S,et al.Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease[J].Metabolisml,2016,65(8):1049-1061.
[23] Giovannucci E,Harlan D,Archer M,et al.Diabetes and cancer:A consensus report[J].Diabetes Care,2010,33(7):1674-1685.
[24] Camont L,Chapman M,Kontush A.Biological activities of HDL subpopulations and their relevance to cardiovascular disease[J].Trends in Molecular Medicine,2011,17(10):594-603.

相似文献/References:

[1]刘 颖,李远辙,周声毅,等.脉冲电磁场调控SREBP1c及氧化应激改善db/db小鼠肝脂肪变性研究*[J].陕西医学杂志,2019,(9):1107.
　LIU Ying,LI Yuanzhe,ZHOU Shengyi,et al.Pulsed electromagnetic fields improves hepatic steatosis 〖JZ〗in db/db mice by SREBP1c and oxidative stress[J].,2019,(6):1107.
[2]刘玲娇,余湘尤,虢小丽.西安市职业人群非酒精性脂肪性肝病患病率及其危险因素调查研究[J].陕西医学杂志,2021,50(1):107.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.029]
　LIU Lingjiao,YU Xiangyou,GUO Xiaoli.Prevalence and risk factors of nonalcoholic fatty liver disease among occupational population in Xi'an[J].,2021,50(6):107.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.029]
[3]赵梦溪,罗 斌,吕建瑞,等.隐丹参酮治疗小鼠非酒精性脂肪性肝病效果及机制研究[J].陕西医学杂志,2023,52(9):1135.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.005]
　ZHAO Mengxi,LUO Bin,LYU Jianrui,et al.Effect and mechanism of cryptotanshinone on nonalcoholic fatty liver disease in mice[J].,2023,52(6):1135.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.005]
[4]梁 娜,张泽天,孙晓冉,等.低密度脂蛋白相关受体蛋白6基因多态性与非酒精性脂肪性肝病发病关系研究[J].陕西医学杂志,2023,52(9):1241.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.030]
　LIANG Na,ZHANG Zetian,SUN Xiaoran,et al.Relationship between low-density lipoprotein receptor-related protein 6 gene polymorphism and occurrence of nonalcoholic fatty liver disease[J].,2023,52(6):1241.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.030]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81700735)
更新日期/Last Update: 2023-06-05